ANIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Anixa Biosciences Inc (ANIX) does not present a strong buy opportunity at the moment for a beginner, long-term investor. The lack of positive financial performance, absence of significant trading trends, and no clear technical or proprietary trading signals suggest holding off on investment for now.
The MACD is positive and expanding, indicating a mild bullish momentum. RSI is neutral at 68.509, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot point (2.902) and resistance level (3.018), showing limited upward momentum.
NULL identified. No recent news or significant trading trends from hedge funds or insiders. Technical indicators show mild bullishness but lack strong momentum.
The company's financial performance is weak, with declining net income (-6.52% YoY) and EPS (-11.11% YoY). No recent news or event-driven catalysts. No recent congress trading data or influential figure involvement.
In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -$2,695,000 (-6.52% YoY), and EPS decreased to -0.08 (-11.11% YoY). Gross margin remained at 0, showing no improvement.
No data available for analyst ratings or price target changes.
